ARCHIVES

DCT Board Okays Extension Of Phase 1 Master Agreements, Increase To $4 Million

This article is from The Cancer Letter archive.

Vol. 13 No. 09 | February 27, 1987

Download PDF Visit The Full Archive

Related Articles

Cooperative Groups Won’t Get Grants For Head & Neck Cancer, Must Compete For Contract Awards

July 1, 1977

Conversation with The Cancer Letter: Einhorn: “I Still Harbor Hope For Similar Success Stories”

October 24, 2014

Rabson Replaces Berlin At Div. Of Biology, Diagnosis

February 14, 1975

Researchers Identify Mutation Linked to Inherited Risk of ALL

September 27, 2013

Gene Patterns Predict Lymphoma Response To Treatment

June 28, 2002

Abraxane Improves Progression-Free Survival Compared to Decarbazine In Stage IV Disease

November 30, 2012